TROP2 is overexpressed in several carcinomas, such as colorectal, pancreatic, gastric, oral squamous cell carcinoma, ovarian, and breast cancers, compared with the corresponding normal tissue [13–18]. This evidence concerns the gene TACSTD2 and breast carcinoma.